AGL three-lens brief
Evidence-based stock research on AGL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $115.08 — 24% above current (13 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $115.08 — 24% above current (13 analysts).
- Negative free cash flow last quarterly (-$145.68M).
AGL closed at $92.60 (-1.06%) as of 2026-09-11. Market cap: $1.55B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $115.08 — 24% above current (13 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; negative free cash flow last quarterly (-$145.68M).. Last quarter: Revenue $1.49B, net income $17.96M, free cash flow -$145.68M.
Why three lenses on AGL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AGLacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AGL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AGL brief"></iframe>